Latest Insider Transactions at Alkermes Plc. (ALKS)
This section provides a real-time view of insider transactions for Alkermes Plc. (ALKS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Alkermes plc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Alkermes plc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+3.48%
|
-
|
|
Feb 17
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,492
-0.7%
|
$28,348
$19.97 P/Share
|
|
Feb 17
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+1.4%
|
-
|
|
Feb 17
2021
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
3,869
-0.5%
|
$73,511
$19.97 P/Share
|
|
Feb 17
2021
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Exercise of conversion of derivative security
|
Direct |
8,750
+1.11%
|
-
|
|
Feb 16
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
825
-2.01%
|
$15,675
$19.79 P/Share
|
|
Feb 16
2021
|
Iain Michael Brown SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,375
+5.48%
|
-
|
|
Feb 16
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,172
-1.82%
|
$22,268
$19.79 P/Share
|
|
Feb 16
2021
|
David Joseph Gaffin EVP, CLO, Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+4.99%
|
-
|
|
Feb 16
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,172
-6.44%
|
$22,268
$19.79 P/Share
|
|
Feb 16
2021
|
Craig C. Hopkinson EVP R&D, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+15.64%
|
-
|
|
Feb 16
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
825
-1.35%
|
$15,675
$19.79 P/Share
|
|
Feb 16
2021
|
Blair Curtis Jackson EVP, Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,375
+3.75%
|
-
|
|
Feb 16
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,678
-0.8%
|
$31,882
$19.79 P/Share
|
|
Feb 16
2021
|
Michael J Landine SVP, Corp Dev., Alkermes, Inc. |
BUY
Exercise of conversion of derivative security
|
Direct |
3,375
+1.58%
|
-
|
|
Feb 16
2021
|
Richard F Pops Director and CEO, Alkermes plc |
SELL
Payment of exercise price or tax liability
|
Direct |
8,074
-1.04%
|
$153,406
$19.79 P/Share
|
|
Feb 16
2021
|
Richard F Pops Director and CEO, Alkermes plc |
BUY
Exercise of conversion of derivative security
|
Direct |
18,125
+2.28%
|
-
|
|
Jan 13
2021
|
Wendy L Dixon Director |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+41.4%
|
$420,000
$12.62 P/Share
|
|
Oct 01
2020
|
Paul J Mitchell Director |
SELL
Open market or private sale
|
Indirect |
20,000
-74.07%
|
$320,000
$16.61 P/Share
|
|
Oct 01
2020
|
Paul J Mitchell Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
20,000
+42.55%
|
$280,000
$14.92 P/Share
|
|
Sep 28
2020
|
David W Anstice Director |
SELL
Open market or private sale
|
Direct |
17,832
-20.68%
|
$285,312
$16.79 P/Share
|
|
Sep 28
2020
|
David W Anstice Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+18.83%
|
$280,000
$14.92 P/Share
|